Howe & Rusling’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-25
Closed -$2K 822
2020
Q1
$2K Sell
25
-1
-4% -$96 ﹤0.01% 625
2019
Q4
$3K Hold
26
﹤0.01% 613
2019
Q3
$2K Hold
26
﹤0.01% 670
2019
Q2
$3K Sell
26
-2
-7% -$195 ﹤0.01% 593
2019
Q1
$3K Sell
28
-1
-3% -$89 ﹤0.01% 602
2018
Q4
$2K Buy
29
+8
+38% +$727 ﹤0.01% 656
2018
Q3
$2K Hold
21
﹤0.01% 706
2018
Q2
$2K Hold
21
﹤0.01% 660
2018
Q1
$2K Sell
21
-1
-5% -$116 ﹤0.01% 765
2017
Q4
$3K Hold
22
﹤0.01% 624
2017
Q3
$2K Hold
22
﹤0.01% 736
2017
Q2
$2K Hold
22
﹤0.01% 798
2017
Q1
$2K Sell
22
-3
-12% -$259 ﹤0.01% 828
2016
Q4
$2K Hold
25
﹤0.01% 847
2016
Q3
$2K Buy
+25
New +$2.51K ﹤0.01% 842

Other funds holding CRI

Howe & Rusling's CRI Position: Q2 2020 in Review

Howe & Rusling sold out of Carter's (CRI) in Q2 2020, closing a stake of 25 shares — an estimated $2K sold.

Howe & Rusling first reported a position in CRI in Q3 2016 and held it in 15 quarters. The position peaked at $3K in Q4 2019. 302 funds tracked by Wall St. Rank hold CRI as of Q2 2020.

  • Howe & Rusling reported no remaining Carter's position as of Q2 2020 after selling out during the quarter.
  • Howe & Rusling sold 25 Carter's shares in Q2 2020, an estimated $2K.
  • Howe & Rusling first reported a position in Carter's in Q3 2016 and held it in 15 quarters.
  • Howe & Rusling's Carter's position peaked at $3K in Q4 2019.
  • 302 funds tracked by Wall St. Rank held Carter's as of Q2 2020.

Based on Howe & Rusling's 13F filing for Q2 2020, filed 15 Jul 2020.